Generic ArimidexA patent currently puts a stop to any generic Arimidex from currently being manufactured in the United States. The clair is set to expire in December 2010. However, additional patents intended for specific uses or legal cases could cause this exclusivity period to give beyond this time. Once the obvious expires, several companies need to begin producing generic Arimidex.

Common Arimidex: An OverviewArimidex® (anastrozole) is a prescription medication employed to treat breast cancer in postmenopausal most women. It is part of a group of medicinal drugs called aromatase inhibitors. Arimidex is manufactured by means of AstraZeneca Pharmaceuticals. It is currently underneath the protection of a patent this prevents any generic Arimidex out of being manufactured in the United States.